BrainChip Fields Akida in Live Drone Test While Cleaning Up Share Count
05.06.2026 - 18:37:43 | boerse-global.de
The Australian neuromorphic chip developer BrainChip is getting a real-world workout this week in Santa Barbara, California, as engineering teams at Raytheon’s “Operation Touchdown” put the Akida AKD1000 processor through its paces. Student groups are tasked with autonomously landing a drone on a moving ground vehicle — a high-stakes demonstration of edge-based AI processing that consumes minimal power and requires no constant cloud link. BrainChip supplies the hardware at cost and offers up to 40 hours of virtual support, though no guaranteed follow-on contract from Raytheon exists.
That sort of hands-on visibility has helped the stock gain around 15% over the past 30 days, closing Thursday at €0.12. Yet the same period brought a separate, quieter development: the company corrected its outstanding Restricted Share Units to roughly 34 million, a figure below what was previously communicated. The revision offers shareholders clearer insight into the potential dilution, though with annual revenue of just under $1.9 million, BrainChip remains deep in its investment cycle.
The broader chip sector has been anything but calm. Broadcom recently posted a 49% revenue jump to $22.19 billion, only to be punished by the market for not raising its AI revenue targets for 2027. The souring mood spilled over onto Intel, AMD, and Qualcomm. BrainChip, by contrast, rose more than 13% in the last seven days — a divergence that highlights its niche appeal as a pure-play edge-AI name. OpenAI alone is slated to spend around $50 billion on computing capacity in 2026 as part of a trillion-dollar AI infrastructure program, reinforcing the argument that when the cloud build-out matures, local processing intelligence could become the next growth wave.
Should investors sell immediately? Or is it worth buying BrainChip?
For now, the stock sits about 21% above its 50-day moving average, recovering nearly 50% from the February 52-week low of €0.08. The relative strength index stands at 64.8, not yet overbought, but the 30-day annualized volatility of roughly 75% leaves little margin for error. Community-based fair value estimates peg BrainChip at between A$0.34 and A$1.17, a wide gap from the current market price that investors can read as either opportunity or warning.
The real test, however, shifts from Santa Barbara to the commercial arena. BrainChip’s management must now convert student trials into paying industrial clients — through partnerships like the one with ForwardEdge ASIC, or platforms such as AkidaTag and Radar. Without concrete licensing deals, the recent rally risks being little more than a sentiment-driven bounce. The hardware has proven it can work in a controlled field exercise; the question is whether it can win in the marketplace.
Ad
BrainChip Stock: New Analysis - 5 June
Fresh BrainChip information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
